Zentalis Pharmaceuticals, Inc. (ZNTL)
1.695
+0.02
(+0.89%)
USD |
NASDAQ |
Nov 13, 16:00
1.695
0.00 (0.00%)
After-Hours: 19:59
Zentalis Pharmaceuticals EPS Diluted (Quarterly) : -0.3406 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.3406 |
| June 30, 2026 | -0.5929 |
| March 31, 2026 | -0.5031 |
| December 31, 2025 | -0.4914 |
| September 30, 2025 | -0.37 |
| June 30, 2025 | -0.3733 |
| March 31, 2025 | -0.6736 |
| December 31, 2024 | -0.6664 |
| September 30, 2024 | -0.5647 |
| June 30, 2024 | -1.243 |
| March 31, 2024 | 0.1414 |
| December 31, 2023 | -0.8608 |
| September 30, 2023 | -0.7864 |
| June 30, 2023 | -1.851 |
| March 31, 2023 | -1.066 |
| December 31, 2022 | -0.9273 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.9576 |
| June 30, 2022 | -1.337 |
| March 31, 2022 | -1.306 |
| December 31, 2021 | -1.113 |
| September 30, 2021 | -0.094 |
| June 30, 2021 | -1.340 |
| March 31, 2021 | -1.236 |
| December 31, 2020 | -0.982 |
| September 30, 2020 | -0.9103 |
| June 30, 2020 | -0.7818 |
| March 31, 2020 | -0.4495 |
| December 31, 2019 | -0.4043 |
| September 30, 2019 | -2.204 |
| June 30, 2019 | -0.2918 |
| March 31, 2019 | -0.2325 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ARS Pharmaceuticals, Inc. | -0.357 |
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | -0.0232 |
| Savara, Inc. | -0.1691 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -28.82M |
| Total Expenses (Quarterly) | 28.82M |
| Enterprise Value | -27.11M |
| Earnings Yield | -113.7% |
| Normalized Earnings Yield | -114.45 |